Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $23.17 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 34.16 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.
Western Asset Intermediate Muni Fund Inc. (SBI) formed double bottom with $8.49 target or 9.00% below today’s $9.33 share price. Western Asset Intermediate Muni Fund Inc. (SBI) has $ valuation. The stock decreased 0.32% or $0.03 during the last trading session, reaching $9.33. About 23,322 shares traded or Infinity% up from the average. Western Asset Intermediate Muni Fund Inc. (NYSE:SBI) has declined 7.31% since January 13, 2017 and is downtrending. It has underperformed by 24.01% the S&P500.
The stock increased 1.31% or $0.93 during the last trading session, reaching $71.73. About 1.45M shares traded. Agilent Technologies, Inc. (A) has risen 25.96% since January 13, 2017 and is uptrending. It has outperformed by 9.26% the S&P500.
Ratings analysis reveals 100% of Agilent’s analysts are positive. Out of 2 Wall Street analysts rating Agilent, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $51.0 while the high is $54.0. The stock’s average target of $52.50 is -26.81% below today’s ($71.73) share price. A was included in 2 notes of analysts from January 4, 2017. The stock of Agilent Technologies, Inc. (NYSE:A) has “Buy” rating given on Wednesday, January 18 by Deutsche Bank. The stock of Agilent Technologies, Inc. (NYSE:A) earned “Overweight” rating by Barclays Capital on Wednesday, January 4.
Hoplite Capital Management L.P. holds 10.17% of its portfolio in Agilent Technologies, Inc. for 2.49 million shares. Antipodean Advisors Llc owns 134,000 shares or 7.26% of their US portfolio. Moreover, Impax Asset Management Ltd has 4.14% invested in the company for 2.11 million shares. The California-based Sensato Investors Llc has invested 3.97% in the stock. Hahn Capital Management Llc, a California-based fund reported 598,781 shares.
Analysts await Agilent Technologies, Inc. (NYSE:A) to report earnings on February, 13. They expect $0.58 earnings per share, up 9.43% or $0.05 from last year’s $0.53 per share. A’s profit will be $187.35M for 30.92 P/E if the $0.58 EPS becomes a reality. After $0.67 actual earnings per share reported by Agilent Technologies, Inc. for the previous quarter, Wall Street now forecasts -13.43% negative EPS growth.